Alfuzosin-Mepha retard, Retardtabletten

7680681380030 CH-68138 Tabletten

Associated product:

ALFUZOSIN Mepha retard cpr ret 10 mg 90 pce
Alfuzosin-Mepha retard, Retardtabletten
Alfuzosin-Mepha retard, Retardtabletten
Alfuzosin-Mepha retard, Retardtabletten
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/06/2022
Patient information leaflet
Français
10/06/2022
Patient information leaflet
Italien
10/06/2022
Summary of Product Characteristics
Allemand
10/06/2022
Summary of Product Characteristics
Français
10/06/2022
Summary of Product Characteristics
Italien
10/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
8.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 55.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68138
Drug name
Alfuzosin-Mepha retard, Retardtabletten
Galenic form
RETT
ATC Code
G04CA01
Authorization status
Z
Dispensing category
B
First authorization
15/10/2020
Authorization expiration date
31/12/9999
IT Number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Package details

Description (FR)
ALFUZOSIN Mepha retard cpr ret 10 mg 90 pce
Description (DE)
ALFUZOSIN Mepha retard Ret Tabl 10 mg 90 Stk
Market launch
15/10/2020
Narcotic (BTM)
No

Original drug

Xatral uno, comprimés retard
GTIN: 7680551880011
CHF 32.65
View original

Other package sizes (2)

ALFUZOSIN Mepha retard cpr ret 10 mg 10 pce
10 TABL
GTIN: 7680681380016
View
ALFUZOSIN Mepha retard cpr ret 10 mg 30 pce
30 TABL
GTIN: 7680681380023
View